FNCH — Finch Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Finch Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	42.2	99.7	133	71	25.1
Net Total Accounts Receivable
Net Total Receivables	4.75	1.09	0.494	0.144	0
Prepaid Expenses
Total Current Assets	48.6	106	143	74.6	25.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.78	7	24.7	48.7	27.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	104	165	225	163	55.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.33	11.5	14.8	14.7	4.08
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	20	28	23.1	67.2	32.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	83.6	137	202	95.7	22.9
Total Liabilities & Shareholders' Equity	104	165	225	163	55.4
Total Common Shares Outstanding